| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/02/2004 | EP1423115A2 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 06/02/2004 | EP1423112A1 A combination of quetiapine and zolmitriptan |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423106A1 Arylsulfonyl derivatives with 5-ht 6 receptor affinity |
| 06/02/2004 | EP1423103A2 Compositions and methods for modulation of darpp-32 phosphorylation |
| 06/02/2004 | EP1423102A1 Plaster for the treatment of dysfunctions and disorders of nail growth |
| 06/02/2004 | EP1423100A1 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole |
| 06/02/2004 | EP1423099A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423095A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/02/2004 | EP1423094A2 A new method |
| 06/02/2004 | EP1423092A2 Functional powders for oral delivery |
| 06/02/2004 | EP1423081A2 Composition comprising glycosaminogycans and hyaluronidase inhibitors for the treatment of arthritic joints |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1326613B1 Use of substituted imidazo 1,2-a]pyridine-, imidazo [1,2-a]pyrimidine and imidazo [1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1214589B1 Method and device for detecting and isolating pharmacological compounds being contained in substance mixtures |
| 06/02/2004 | EP1204662B1 Azaindoles having serotonin receptor affinity |
| 06/02/2004 | EP0941105A4 Pretraumatic use of hemoglobin |
| 06/02/2004 | EP0828500B1 Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast |
| 06/02/2004 | CN1501976A Crf2 ligands in combination therapy |
| 06/02/2004 | CN1501942A Diaryl peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501935A Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 06/02/2004 | CN1501932A Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501929A Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501928A Small molecule compositions for binding to hsp90 |
| 06/02/2004 | CN1501927A Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 06/02/2004 | CN1501926A Mercaptoacetylamide derivatives, process for their preparation and use thereof |
| 06/02/2004 | CN1501922A Remedies |
| 06/02/2004 | CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/02/2004 | CN1501910A Crystalline forms of venlafaxine hydrochloride |
| 06/02/2004 | CN1501909A Novel succinate salt of o-desmethyl-venlafaxine |
| 06/02/2004 | CN1501903A Stable solution of reduced coenzyme q |
| 06/02/2004 | CN1501828A Dapd combination therapy with inosine monophosphate dehydrogenase inhibitor |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501813A Visual function improving agents |
| 06/02/2004 | CN1501811A Compositions for stimulating cytokine secretion and inducing an immune response |
| 06/02/2004 | CN1501808A The use of the protein uk114 for the treatment and the prevention of chronic active hepatitis |
| 06/02/2004 | CN1501806A Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/02/2004 | CN1501804A Acrochordon alleviation |
| 06/02/2004 | CN1501800A Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 06/02/2004 | CN1501798A Medicinal compositions comprising diclofenac and ornoprostil |
| 06/02/2004 | CN1501797A Anti-proliferative drugs |
| 06/02/2004 | CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 06/02/2004 | CN1500820A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500508A Anti-age capsule of traditional Chinese medicine and preparation method |
| 06/02/2004 | CN1152051C Trichosanthin mutant and preparing method thereof |
| 06/02/2004 | CN1152049C Treatment of insulin resistance with growth hormone secretagogues |
| 06/02/2004 | CN1152048C Perfluoroalkyl ketone inhibitors of elastase and preparing method thereof |
| 06/02/2004 | CN1152046C Betulinic acid derivatives, preparing method thereof and application in treating tumor related to angiogenesis |
| 06/02/2004 | CN1152042C Partial or full A agonists-N heterocyclic 5' thio substituted adenosine devivatives |
| 06/02/2004 | CN1152031C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/02/2004 | CN1152025C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/02/2004 | CN1152024C Substituted 3-phenyl-5-alkoxl-1,3,4-oxidazol-2-ones and use as lipase inhibitors thereof |
| 06/02/2004 | CN1152023C Substituted polycyclic aryl and hetero aryl uracils as anticoagulant |
| 06/02/2004 | CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof |
| 06/02/2004 | CN1152016C 2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1152011C Vitamin D analogues and pharmaceutical uses thereof |
| 06/02/2004 | CN1152006C Biphenyl derivatives |
| 06/02/2004 | CN1151841C Application of interferons(IFN) in preparation of pharmaceutics for stimulation of defence mechanism or immune reaction |
| 06/02/2004 | CN1151825C Health tonic for delaying senility and regualting blood lipid |
| 06/02/2004 | CN1151797C Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/02/2004 | CN1151795C Drugs containing sulfopyranosylacylglycerol derivatives |
| 06/02/2004 | CN1151793C Medicinal composition for treating osseous lesion in multiple myeloma |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/02/2004 | CN1151778C Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743941 Process for the production of piperidine derivatives |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743924 Method for producing 1-substituted-1,2,3-triazole derivative |
| 06/01/2004 | US6743913 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and α-1-blocking action |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743815 Estrogen receptor modulators |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743805 Treating vascular proliferative disorders |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 06/01/2004 | US6743792 Antiinflammatory agents |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 06/01/2004 | US6743789 Substituted imidazo[1,5-a][1,2,4]triazolo[4,3-d][1,4]benzodiazepine derivatives |
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 06/01/2004 | US6743774 Tribonectins |
| 06/01/2004 | US6743426 Administering protein c; avoiding bleeding, toxicity and side effects of anticoagulant agents |
| 06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
| 06/01/2004 | CA2315871C Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
| 06/01/2004 | CA2295108C Method of enhancing magnesium absorption and prevention of atherosclerosis |
| 06/01/2004 | CA2293336C Methods of using isomer enriched conjugated linoleic acid compositions |